Liquamox® C IS synergistic antibiotic combination with broad spectrum bacterial resistance inhibitor

Liquamox® C IS

Synergistic Antibiotic Combination with Broad Spectrum Bacterial Resistance Inhibitor

Canines Felines Injectable Suspension

Amoxicillin (as Trihydrate) 14 g, Clavulanic Acid (as Potassium Clavulanate) 3.5 g

Treatment and prevention of infections caused by strains sensitive to the association amoxicillin + clavulanic acid (including those that produce beta-lactamases); among them: respiratory infections, urinary infections, gastrointestinal infections, periodontal infections and gingivitis, skin and soft tissue infections (e.g. abscesses, pyoderma, cellulitis, anal sacculitis and endocarditis)

Subcutaneous injectable: 1 mL/20 kg b.w daily.
Bottle x 50 mL , Bottle x 100 mL .

SENASA Registry: Reg. SENASA Perú: F.082.042.I.00719.

This content is informative reference and should not be considered as prescriptions.

You may also be interested

Amoxigentin®
Amoxigentin®
Broad-spectrum synergistic antibiotic combination
Injectable Suspension
Tylamox® WS
Tylamox® WS
Broad-spectrum Macrolide Beta-lactam Synergic-additive Antibiotic Association
Soluble Powder
Vetamoxyl® 20 L.A.
Vetamoxyl® 20 L.A.
Broad-spectrum penicillanic semisynthetic antibiotic.
Injectable Suspension